• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰首发冠心病风险预测:SCORE 风险函数的再估计和改进。

Risk prediction of incident coronary heart disease in The Netherlands: re-estimation and improvement of the SCORE risk function.

机构信息

Department of Epidemiology, CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands.

出版信息

Eur J Prev Cardiol. 2012 Aug;19(4):840-8. doi: 10.1177/1741826711410256. Epub 2011 May 6.

DOI:10.1177/1741826711410256
PMID:21551214
Abstract

AIMS

To re-estimate the SCORE risk function using individual data on risk factors and coronary heart disease (CHD) incidence from the Dutch Cardiovascular Registry Maastricht (CAREMA) population-based cohort study; to evaluate changes that may improve risk prediction after re-estimation; and to compare the performance of the resulting CAREMA risk function with that of existing risk scores.

METHODS AND RESULTS

The cohort consisted of 21,148 participants, born in 1927-1977 and randomly sampled from the Maastricht region in 1987-1997. After follow-up (median 10.9 years), 783 incident CHD cases occurred. Model performance was assessed by discrimination and calibration. The additional value of including other risk factors or current risk factors in a different manner was evaluated using the net reclassification index (NRI). The c statistic of the re-estimated SCORE model was 0.799 (95% CI 0.782-0.816). Separating the total/high-density lipoprotein (HDL) cholesterol ratio into total and HDL cholesterol levels did not improve the c statistic (p = 0.22), but reclassified 6.0% of the participants into a more appropriate risk category (p < 0.001) compared with the re-estimated model. The resulting CAREMA function reclassified 28% of the participants into a more appropriate risk category than the Framingham score. Compared with the SCORE functions for high- and low-risk regions, the NRIs were 28% and 35%, respectively, which can largely be explained by the difference in outcome definition (CHD incidence vs. CHD mortality).

CONCLUSION

In this Dutch population, a re-estimated SCORE function with total and HDL cholesterol levels instead of the cholesterol ratio can be used for the risk prediction of CHD incidence.

摘要

目的

使用荷兰心血管登记处马斯特里赫特(CAREMA)基于人群的队列研究中的个体危险因素和冠心病(CHD)发病数据重新估计 SCORE 风险函数;评估重新估计后可能改善风险预测的变化;并比较由此产生的 CAREMA 风险函数与现有风险评分的性能。

方法和结果

该队列由 21148 名参与者组成,出生于 1927 年至 1977 年,于 1987 年至 1997 年从马斯特里赫特地区随机抽样。随访(中位数 10.9 年)后,发生了 783 例冠心病事件。通过区分度和校准评估模型性能。使用净重新分类指数(NRI)评估以不同方式纳入其他危险因素或当前危险因素的附加价值。重新估计的 SCORE 模型的 c 统计量为 0.799(95%CI 0.782-0.816)。将总/高密度脂蛋白(HDL)胆固醇比值分为总胆固醇和 HDL 胆固醇水平并没有提高 c 统计量(p=0.22),但与重新估计的模型相比,有 6.0%的参与者被重新分类到更合适的风险类别(p<0.001)。与重新估计的模型相比,由此产生的 CAREMA 函数将 28%的参与者重新分类到更合适的风险类别。与高风险和低风险地区的 SCORE 函数相比,NRI 分别为 28%和 35%,这主要可以用结局定义(CHD 发病率与 CHD 死亡率)的差异来解释。

结论

在荷兰人群中,用总胆固醇和 HDL 胆固醇水平代替胆固醇比值的重新估计的 SCORE 函数可用于 CHD 发病率的风险预测。

相似文献

1
Risk prediction of incident coronary heart disease in The Netherlands: re-estimation and improvement of the SCORE risk function.荷兰首发冠心病风险预测:SCORE 风险函数的再估计和改进。
Eur J Prev Cardiol. 2012 Aug;19(4):840-8. doi: 10.1177/1741826711410256. Epub 2011 May 6.
2
Co-occurrence of metabolic factors and the risk of coronary heart disease: a prospective cohort study in the Netherlands.代谢因素的共同发生与冠心病风险:荷兰的前瞻性队列研究。
Int J Cardiol. 2012 Mar 8;155(2):223-9. doi: 10.1016/j.ijcard.2010.09.047. Epub 2010 Oct 20.
3
Risk scores of common genetic variants for lipid levels influence atherosclerosis and incident coronary heart disease.常见血脂水平遗传变异风险评分影响动脉粥样硬化和冠心病事件。
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2233-9. doi: 10.1161/ATVBAHA.113.301236. Epub 2013 Jun 13.
4
Multilocus genetic risk scores for coronary heart disease prediction.多基因遗传风险评分用于冠心病预测。
Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2267-72. doi: 10.1161/ATVBAHA.113.301218. Epub 2013 May 16.
5
C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.C反应蛋白基于弗明汉姆评分调节风险预测:对未来风险评估的启示:来自德国南部一项大型队列研究的结果
Circulation. 2004 Mar 23;109(11):1349-53. doi: 10.1161/01.CIR.0000120707.98922.E3. Epub 2004 Mar 15.
6
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.低发病人群中冠状动脉事件的预测。评估CUORE队列研究预测方程的准确性。
Int J Epidemiol. 2005 Apr;34(2):413-21. doi: 10.1093/ije/dyh405. Epub 2005 Jan 19.
7
Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference.冠心病风险预测算法在表现出性别差异的土耳其成年人中需要纳入 C 反应蛋白。
Nutr Metab Cardiovasc Dis. 2012 Aug;22(8):643-50. doi: 10.1016/j.numecd.2010.10.010. Epub 2011 Feb 11.
8
Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular risk.血压和血脂附加测量对心血管风险预测的影响。
Eur J Prev Cardiol. 2012 Dec;19(6):1474-85. doi: 10.1177/1741826711424494. Epub 2011 Sep 26.
9
Validity of the Framingham point scores in the elderly: results from the Rotterdam study.弗雷明汉积分在老年人中的有效性:鹿特丹研究结果
Am Heart J. 2007 Jul;154(1):87-93. doi: 10.1016/j.ahj.2007.03.022.
10
Linoleic acid intake, plasma cholesterol and 10-year incidence of CHD in 20,000 middle-aged men and women in the Netherlands.亚麻酸摄入量、血浆胆固醇与荷兰 2 万名中老年男女 10 年冠心病发病风险
Br J Nutr. 2012 Apr;107(7):1070-6. doi: 10.1017/S0007114511003837. Epub 2011 Aug 5.

引用本文的文献

1
Research inefficiencies in external validation studies of the Framingham Wilson coronary heart disease risk rule: A systematic review.弗雷明汉威尔逊冠心病风险规则外部验证研究中的研究效率低下:系统评价。
PLoS One. 2024 Sep 13;19(9):e0310321. doi: 10.1371/journal.pone.0310321. eCollection 2024.
2
Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection.心血管疾病一级预防的风险评估:适当风险预测模型选择的考虑因素。
Lancet Glob Health. 2024 Aug;12(8):e1343-e1358. doi: 10.1016/S2214-109X(24)00210-9.
3
Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice.
SCORE 和 Globorisk 心血管风险预测模型的表现:荷兰普通实践中的前瞻性队列研究。
Br J Gen Pract. 2022 Dec 21;73(726):e24-e33. doi: 10.3399/BJGP.2021.0726. Print 2023 Jan.
4
Prognostic Modelling Studies of Coronary Heart Disease-A Systematic Review of Conventional and Genetic Risk Factor Studies.冠心病的预后模型研究——传统和遗传危险因素研究的系统评价
J Cardiovasc Dev Dis. 2022 Sep 5;9(9):295. doi: 10.3390/jcdd9090295.
5
Cohen's Kappa Coefficient as a Measure to Assess Classification Improvement following the Addition of a New Marker to a Regression Model.科恩氏 Kappa 系数作为评估回归模型中新增标记物后分类改善的指标。
Int J Environ Res Public Health. 2022 Aug 17;19(16):10213. doi: 10.3390/ijerph191610213.
6
Developing and Validating Risk Scores for Predicting Major Cardiovascular Events Using Population Surveys Linked with Electronic Health Insurance Records.利用人群调查与电子健康保险记录关联,开发和验证预测主要心血管事件的风险评分。
Int J Environ Res Public Health. 2022 Jan 25;19(3):1319. doi: 10.3390/ijerph19031319.
7
Re-estimation improved the performance of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis.再估算改进了两种弗雷明汉心血管风险方程和队列方程的性能:一项全国性登记分析。
Sci Rep. 2020 May 18;10(1):8140. doi: 10.1038/s41598-020-64629-6.
8
Cardiovascular risk assessment: a global perspective.心血管风险评估:全球视角。
Nat Rev Cardiol. 2015 May;12(5):301-11. doi: 10.1038/nrcardio.2015.28. Epub 2015 Mar 10.
9
Trabecular bone score may improve FRAX® prediction accuracy for major osteoporotic fractures in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.小梁骨评分可能会提高FRAX®对老年日本男性主要骨质疏松性骨折的预测准确性:藤原京男性骨质疏松风险(FORMEN)队列研究。
Osteoporos Int. 2015 Jun;26(6):1841-8. doi: 10.1007/s00198-015-3092-3. Epub 2015 Mar 10.
10
Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation-The POWER Survey.降压治疗对SCORE评估的总体心血管风险的影响:一项开放标签、多国研究——POWER调查的结果
Int J Hypertens. 2013;2013:165789. doi: 10.1155/2013/165789. Epub 2013 Jul 25.